2015
DOI: 10.1158/1541-7786.mcr-14-0277-t
|Get access via publisher |Cite
|
Sign up to set email alerts

p53 Mutation Directs AURKA Overexpression via miR-25 and FBXW7 in Prostatic Small Cell Neuroendocrine Carcinoma

Abstract: Prostatic small cell neuroendocrine carcinoma (SCNC) is a rare but aggressive form of prostate cancer (PCa) that is negative for androgen receptor (AR) and not responsive to hormonal therapy. The molecular etiology of this PCa variant is not well understood; however, mutation of the p53 (TP53) tumor suppressor in prostate neuroendocrine cells inactivates the IL8-CXCR2-p53 pathway that normally inhibits cellular proliferation, leading to the development of SCNC. SCNC also overexpresses Aurora kinase A (AURKA) w… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
53
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations

"V体育ios版" Cited by 71 publications

(55 citation statements)
references

References VSports在线直播 - 38 publications

2
53
0
Order By: Relevance